ID   BL-14B
AC   CVCL_ZI23
SY   BL14B; BL 14B; BL 014B; IARC/BL14B; IARC/BL 14B; IARC-BL14B; IARC BL14B; IARC BL 14B
DR   Wikidata; Q98125584
RX   PubMed=3026973;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Turkish.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M558 ! BL-14
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
RX   PubMed=3026973; DOI=10.1002/ijc.2910390215;
RA   Ehlin-Henriksson B., Manneborg-Sandlund A., Klein G.;
RT   "Expression of B-cell-specific markers in different Burkitt lymphoma
RT   subgroups.";
RL   Int. J. Cancer 39:211-218(1987).
//
RX   PubMed=11793449; DOI=10.1002/gcc.10022;
RA   Sobol H., Benziane A., Kerangueven F., Yin L., Noguchi T., Pauly S.,
RA   Eisinger F., Longy M., Romeo G., Lenoir G.M., Birnbaum D.;
RT   "Genome-wide search for loss of heterozygosity in Burkitt lymphoma
RT   cell lines.";
RL   Genes Chromosomes Cancer 33:217-224(2002).
//